Corvus Pharmaceuticals, Inc. - CRVS
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | — | M | D | 15,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 30, 2026 | — | M | D | 15,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 30, 2026 | — | M | D | 15,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 30, 2026 | — | M | D | 15,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 30, 2026 | — | M | D | 15,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 30, 2026 | — | M | D | 15,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 30, 2026 | — | M | D | 15,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 30, 2026 | — | M | D | 15,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 30, 2026 | — | M | D | 15,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 30, 2026 | — | M | D | 15,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 30, 2026 | — | M | D | 15,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 30, 2026 | — | M | D | 15,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 30, 2026 | — | M | D | 30,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 30, 2026 | — | M | A | 15,000.0 | 2.12 | 31,800.0 | 210,000.0 | View | |
| Jan 30, 2026 | — | M | A | 15,000.0 | 1.64 | 24,600.0 | 195,000.0 | View | |
| Jan 30, 2026 | — | M | A | 15,000.0 | 2.49 | 37,350.0 | 180,000.0 | View | |
| Jan 30, 2026 | — | M | A | 15,000.0 | 0.965 | 14,475.0 | 165,000.0 | View | |
| Jan 30, 2026 | — | M | A | 15,000.0 | 0.9899 | 14,848.5 | 150,000.0 | View | |
| Jan 30, 2026 | — | M | A | 15,000.0 | 2.6 | 39,000.0 | 135,000.0 | View | |
| Jan 30, 2026 | — | M | A | 15,000.0 | 2.74 | 41,100.0 | 120,000.0 | View | |
| Jan 30, 2026 | — | M | A | 15,000.0 | 3.27 | 49,050.0 | 105,000.0 | View | |
| Jan 30, 2026 | — | M | A | 15,000.0 | 2.0 | 30,000.0 | 90,000.0 | View | |
| Jan 30, 2026 | — | M | A | 15,000.0 | 3.61 | 54,150.0 | 75,000.0 | View | |
| Jan 30, 2026 | — | M | A | 15,000.0 | 12.5 | 187,500.0 | 60,000.0 | View | |
| Jan 30, 2026 | — | M | A | 15,000.0 | 9.7 | 145,500.0 | 45,000.0 | View | |
| Jan 30, 2026 | — | M | A | 30,000.0 | 15.0 | 450,000.0 | 30,000.0 | View | |
| Dec 08, 2025 | See Remarks | A | A | 400,000.0 | 0.0 | 0.0 | 400,000.0 | View | |
| Dec 08, 2025 | President and CEO | A | A | 1,000,000.0 | 0.0 | 0.0 | 1,000,000.0 | View | |
| Dec 08, 2025 | Chief Business Officer | A | A | 100,000.0 | 0.0 | 0.0 | 100,000.0 | View | |
| Dec 08, 2025 | Chief Financial Officer | A | A | 400,000.0 | 0.0 | 0.0 | 400,000.0 | View |